S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis

Figure 1

The analyses and indicators used in our study. Differential S100A8 expression analyses were performed in the clinical correlation section between different tissues, ages (=65 versus >65), genders, stages, and grades. The univariate Cox regression analysis was used for the survival correlation analyses. GSEA was used to investigate relevant signaling pathways based on S100A8 expression in the immune mechanism section. Wilcoxon test was performed on the S100A8 expression of nonresponder and responder groups in the immunotherapeutic response section.